LCOM & Department News

UVM Hosts NIH NERIC Conference & Leahy Visit

August 14, 2017 by Jennifer Nachbur

The Vermont Genetics Network (VGN) and Vermont Center for Immunology and Infectious Diseases (VCIID) at the University of Vermont hosted more than 300 National Institutes of Health-funded biomedical researchers from across Vermont, New Hampshire, Maine, Rhode Island and Delaware for the North East Regional IDeA Conference (NERIC) August 16 to 18, 2017 at the Sheraton Burlington Hotel. U.S. Senator Patrick Leahy delivered remarks at the conference on August 17.
The Vermont Genetics Network (VGN) and Vermont Center for Immunology and Infectious Diseases (VCIID) at the University of Vermont hosted more than 300 National Institutes of Health-funded biomedical researchers from across Vermont, New Hampshire, Maine, Rhode Island and Delaware for the North East Regional IDeA Conference (NERIC) August 16 to 18, 2017 at the Sheraton Burlington Hotel. U.S. Senator Patrick Leahy delivered remarks at the conference on August 17.

Vermont is one of 24 states in the country designated by the National Institutes of Health (NIH) as eligible for Institutional Development Awards (IDeA. The IDeA program, which is based in the Research Capacity Building section of the National Institute of General Medical Sciences, provides funding designed to build the infrastructure for biomedical research in smaller states like Vermont, in order to boost the careers of biomedical researchers, and grow and diversify the biomedical workforce in the state. In general, IDeA awards help develop research programs at both university and baccalaureate institutions and ensure faculty can be competitive for NIH funding.  

Once a decade, the North East Regional IDeA Conference (NERIC) is held in Vermont. The 2017 meeting was led by UVM faculty members and IDeA Award Principle Investigators Judith Van Houten, Ph.D., and Ralph Budd, M.D. Van Houten leads the VGN, which is funded through an INBRE – IDeA Networks of Biomedical Research Excellence – award. UVM also has two COBRE – Center of Biomedical Research Excellence – awards, which support the VCIID, which is led by Budd, and the Vermont Center on Behavior and Health at UVM. The VGN is in its third five-year phase and has been supported by $56 million in IDeA grants. The VCIID has been supported in its three phases by $27 million from IDeA. The newest Center on Behavior and Health is currently supported by an $11.5-million-dollar IDeA grant.  

The goal of the NERIC conference is to provide a platform for biomedical scientists to learn from colleagues about the latest research in the region in the areas of infectious diseases and immunology, neuroscience, bioinformatics, development and genetics, and cancer. A special session on entrepreneurship will feature experts from the NIH, U.S. Patent Office, and business and venture capital fields. In addition, there will be career development sessions for undergraduate and graduate students, who will also have an opportunity to present their research via posters, which allows them to share complex ideas in short, “elevator pitch” style settings. UVM core facilities, which feature the latest cutting-edge technologies and encourage sharing of research resources to stretch tax payers’ dollars, will also be highlighted at the conference.    

Senator Leahy addressed conference attendees about the importance of sustaining funding for agencies such as the NIH, and the Research Capacity Building programs that fund IDeA.  As Vice Chairman of the Senate Appropriations Committee, Leahy has championed funding for such science agencies as the NIH, Centers for Disease Control and Prevention, National Oceanic and Atmospheric Administration, and Environmental Protection Agency.

UVM President Tom Sullivan and Provost David Rosowsky joined Budd and Van Houten in welcoming attendees at the conference’s opening on August 16. 

Among the UVM and VGN faculty members who presented at the NERIC meeting are: Jason Botten, Ph.D., UVM assistant professor of medicine, who recently received a Small Business Technology Transfer (STTR) grant to produce human neutralizing antibodies to hantavirus by cloning the immunoglobulin genes from B cells of patients who have survived hantavirus infection; Iwona Buskiewicz, Ph.D., UVM assistant professor of pathology, a recent R21 grant recipient, who just published an important study in Science Signaling showing that the type I Interferon signature in blood lymphocytes of lupus patients is driven in part by oxidative stress-induced aggregation of a protein known as mitochondrial anti-viral signaling protein (MAVS); Keith Mintz, Ph.D., UVM associate professor of microbiology and molecular genetics, whose work with the VGN Proteomics Core focuses on the identification of proteins needed for fimbrae secretion and biofilm development in the oral pathogen Aggregatibacter actinomycetemcomitans; Bill Landesman, Ph.D., a professor of biology at Green Mountain College, who is conducting a  tick research project with support from a $75,000 grant from VGN; Clarissa Parker, Ph.D., an assistant professor of psychology and neuroscience at Middlebury College, whose research on mapping genes in mice associated with the behavioral and physiological traits that characterize drug withdrawal is supported by a grant from the National Institute on Drug Abuse through NIH’s R15 Academic Research Enhancement Award (AREA) program; Gina Mireault, Ph.D., a professor of behavioral sciences at Johnson State College, whose research project, which involves undergraduate research assistants, is examining how infants discover humor and amusement and how that relates to bonding, attachment and development.

Learn more about the NERIC conference.

 

Past Department Highlights

Congratulations to Anne Stowman, M.D., assistant professor of pathology and laboratory medicine, on accepting the position as Network Vice Chair for Anatomic Pathology. (3/2024)  

Congratulations to Ashley Volaric, M.D., assistant professor of pathology and laboratory medicine, on receiving a Physician-Scientist Pilot Award through the Translational Global Infectious Disease Research (TGIR Group) for her research on Epstein-Barr virus (EBV) epigenetics of diffuse large B-cell lymphomas in sub-Saharan Africa. (3/2024)

Congratulations to Rebecca Wilcox, M.D., associate dean for faculty affairs, and professor of pathology and laboratory medicine, on receiving The Polaris Award for Outstanding Mentorship, and Dr. Yvonne Janssen-Heininger, Ph.D., on receiving the Gender Equity Outstanding Achievement in Medicine & Science Award at the 5th Annual Celebration of Gender Equity in Medicine and Science Awards. This award honors a Larner College of Medicine faculty or staff member who provides outstanding formal or informal mnetorship for women or gender diverse** college community members. Dr. Wilcox was nominated by Andrea Green, Julie Dumas, Alexandra Kalof, and LE Faricy. (2/2024) **Gender diverse refers to those who identify with a gender outside of the she/her, he/him binary   

Congratulations to Dr. Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, the team in the Cunniff Lab, and industry partner , RS Oncology, on having their novel therapy enter Phase 2 Clinical trials. Read more here Milestone for UVM-developed cancer drug. (2/2024)

During the annual Larner College of Medicine's Foundations Award Celebration, Amer Abu Alfa, M.D., assistant professor of pathology and laboratory medicine received The Dean Warshaw Integration Award recognizing the faculty member whose teaching best captured the spirit of the Vermont Integrated Curriculum. Congratulations. Christina Wojewoda, M.D., professor of pathology and laboratory medicine and vice chair for education pathology, presented the Ephraim Woll Award for Excellence in General Pathology to John Rustad. (2/2024) 

Congratulations Dr. Bei Zhang, M.D., M.S., Ph.D., MLS(ASCP)CM, on January 17, 2024, is to receive the Educational Scholarship Award from the Teaching Academy Awards for Teaching and Educational Excellence. This award recognizes an individual who has demonstrated a record of Quality, Quantity, and Engagement in medical education scholarship. Dr. Zhang, M.D., M.S., Ph.D., MLS(ASCP)CM, has been advanced to Distinguished Educator by the Teaching Academy at LCOM. Congratulations also to Bronwyn Bryant, M.D., for advancing to the level of Master Teacher and Agnes Balla, M.D., on being inducted as a Member. (1/2024)

Congratulations to University Scholar Mary Cushman, M.D., M.Sc., professor of medicine and pathology and laboratory medicine, on being ranked #90 in the U.S. and #144 in the world as one of the Best Female Scientists in the World, by Research.com. Also, Dr. Cushman, M.D., M.Sc., recently delivered the Robert Reneman Lecture at the Cardiovascular Research Institute Maastricht (CARIM)'s 2023 symposium in The Netherlands. The tile of her talk was "Stroke and Cognitive Impairment in a Biracial U.S. Cohort: The REGARDS Study." (1/2024)

In a recent Nature Methods paper, Doug Taatjes, Ph.D., Director of the Microscopy Imaging Center, and the Center for Biomedical Shared Resources at the Larner College of Medicine, together with colleagues from the international consortium QUAREP-LiMi, proposed a set of standardized community-developed checklists to assist researchers, reviewers, and journal editors with the goal of increasing the clarity and reproducibility of image figures and their analyses. The hope is that many journals will adopt these guidelines as part of their “Instructions for Authors”—providing a succinct and easy to use checklist for authors when compiling images for reproduction and descriptions of image analyses performed. (11/2023) (from the LCOM Newsletter)

Congratulations to some of our residents and our fellowship student on having their abstracts accepted for the upcoming 2024 USCAP annual meeting in March. "Unexpected Cardiac Amyloidsis: Demographics, Histology, Distribution and Clinical Significance: A Review of 15 Autopsy Cases." (Jesse Mostoller, Neel Hedge, Nick Taylor). "GATA3 Positive Malignant Spindle Cell Neoplasm Involving the Liver Diagnosed as Metastatic Sarcomatoid Chromophobe Renal Cell Carcinoma at Autopsy." (Rae Nusapan). "Long Term Outcome in a Case of Tetralogy of Fallot Surgically Treated with Palliative Shunts: Findings from an Adult Autopsy." (Dore Guptil, Heather Giguere). (11/2023)

Mark_FungCongratulations to Dr. Mark Fung, M.D., PhD., Professor Pathology and Laboratory Medicine, on receiving the 2023 College of American Pathologists (CAP) Lifetime Achievement Award. Dr. Fung is a nationally recognized expert in transfusion medicine. (10/2023) 

Congratulations to Jessica Crothers, M.D., Assistant Professor Pathology and Laboratory Medicine, on achieving the Notice of Special Interest Team Science award from NIAID for: "Effects of the gut microbiota on oral vaccine response in adults and children." (10/2023)

Nicole BouffardCongratulations to Nicole Bouffard on being awarded the "Scientific Research Staff Award" for 2023. This was presented to Nicole at the September 21, 2023, LCOM Research Excellence Award Ceremony. This is a great honor for Nicole and the Department of Pathology and recognizes her contributions and importance to the department and MIC. (10/2023)

Congratulations to Brian Cunniff, Ph.D., Assistant Professor Pathology and Laboratory Medicine, on being awarded a $1.6 million R01 grant by the National Institute of General Medical Sciences to study the role of mitochondrial trafficking in regulating cell migration, a key feature of metastatic tumors. (9/2023)

Congratulations to Yvonne Janssen-Heininger, Ph.D., Professor Pathology and Laboratory Medicine, on becoming a University of Vermont Cancer Center Program Co-Leader, Cancer Cell. (9/2023)

Congratulations to the following pathology members on receiving research support funds in April 2023. Recipients were: John Kennedy, M.D., $6520 for morphologic and immunohistochemical re-evaluation of renal cell carcinomas exhibiting papillary architecture, with emphasis on tumors demonstrating "type 2" morphology. Yvonne Janssen-Heininger, Ph.D., $15,000 for a joint initiative between RBP, UVM Cancer Center, and faculty in the Department of Chemistry. Megan Tarte $745 for Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease ConferenceAlbert van der Vliet, Ph.D., $14,400 for Redox processes in macrophage activation in IPF. (9/2023)

Congratulations to the following faculty members on their promotions: Vikas Anathy, Ph.D., to Professor with tenure, Bronwyn Bryant, M.D., to Associate Professor, John DeWitt, M.D., Ph.D., to Associate Professor, Sarah Nowak Ph.D., to Associate Professor, and Christi Wojewoda, M.D., to Professor. (6/2023)

Bei Zhang, M.D., M.S., Ph.D., MLS(ASCP), associate professor of pathology and laboratory medicine, did an educational scholarship session titled "Activate Students Learning Outside Classroom." at the 8th International meeting of the Association of Biochemistry Educators. Dr. Zhang also conducted two additional workshops with other ABE members titled "Linking Clinical Presentations to Their Biochemistry: A novel ABE Clinical-Biochemistry Curricular Treat Mapping Educational Tool.", and "Getting to Clerkship and Beyond: Crafting Biochemistry Learning Objectives that Connect and Integrate Basic Science Concepts with Clinical Application." (5/2023)

Congratulations to Dr. Maureen Harmon, M.D., associate professor of pathology and laboratory medicine, and Dr. Amer Abu Alfa, M.D., assistant professor of pathology and laboratory medicine for being recognized by medical students for their professionalism. Dr. Harmon was recognized for social responsibility and Dr. Abu Alfa was recognized for compassion. (5/2023)

Congratulations to Mary Cushman, Ph.D., M.Sc., professor of medicine and pathology and laboratory medicine, on being named a University Distinguished Professor of Medicine, Hematology/Oncology Division, and Pathology and Laboratory Medicine. (5/2023)

View the story Mammograms of a study by Sarah Nowak, Ph.D., assistant professor of pathology and laboratory medicine, and researchers at the UVM Cancer Center showing data that fewer women being screened for breast cancer. (4/2023)

vandervliet-habibovic420x280A new study by Albert van der Vliet, Ph.D., professor of pathology and laboratory medicine, and a team of University of Vermont (UVM) researchers is honing in on why people with asthma often have worse symptoms if they are obese. This new research demonstrates that the gene DUOX1 likely contributes to the connection between obesity and asthma.  The research was published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology and was highlighted as an APSselect article for March 2023. Albert van der Vliet, Ph.D., was the senior author on the paper, along with department of pathology and laboratory medicine coauthors Aida Habibovic, lab research technician;Litiele Cruz, Ph.D., visiting scholar; Vikas Anathy, Ph.D., associate professor; University Distinguished Professor Yvonne Janssen-Heininger, Ph.D.; and additional team members and authors from UVM. Read the full LCOM News story LCOM News (4/2023)

Congratulations to Bronwyn Bryant, M.D., Assistant Professor of Pathology and Laboratory Medicine, for having your proposal, Consequential Validity of Entrustable Professional Activities in Pathology Residency Training selected to receive a Frymoyer Scholars Program project of $48,000 to be funded July 1, 2023 through June 30, 2025. (4/2023)

Congratulations to Martin Chang, M.D., Ph.D., on accepting the new role as Vice Chair for Faculty Affairs. (4/2023)

Congratulations to Joanna Conant, M.D., on becoming the new Pathology Student Fellowship Director starting July 1, 2023. (4/2023)

Congratulations to The Cunniff Lab, on receiving funding to support research focused on malignant mesothelioma. The funding was from The Butler Family Foundation Fund for Cancer Research at the University of Vermont Cancer Center. The Butler Fund was established by the Butler family in memory of two loved ones lost to mesothelioma. (03/2023)